InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Sunday, 06/30/2013 12:14:42 AM

Sunday, June 30, 2013 12:14:42 AM

Post# of 130503
Per Geralds monthly blog:

"outlined an aggressive growth strategy for the Company’s key products, MANF and LymPro, at a period in their development cycle when significant value can be created with relatively little capital invested over the next 12 months":

Time will tell: but if he sticks to his publicly stated intentions; we should not see any significant solution over the next year (and possibly leading up to commercialization for LymPro). However, there may be some modest dilution....just waiting to see how things play out.

GLTA!!!